Watters AD - Search Results

1

Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization.

Isola J, Tanner M, Forsyth A, Cooke TG, Watters AD, Bartlett JM. Isola J, et al. Among authors: watters ad. Clin Cancer Res. 2004 Jul 15;10(14):4793-8. doi: 10.1158/1078-0432.CCR-0428-03. Clin Cancer Res. 2004. PMID: 15269154

2

Fluorescence in situ hybridization in paraffin tissue sections: pretreatment protocol.

Watters AD, Bartlett JM. Watters AD, et al. Mol Biotechnol. 2002 Jul;21(3):217-20. doi: 10.1385/MB:21:3:217. Mol Biotechnol. 2002. PMID: 12102545

3

Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer.

Watters AD, Latif Z, Forsyth A, Dunn I, Underwood MA, Grigor KM, Bartlett JM. Watters AD, et al. Br J Cancer. 2002 Sep 9;87(6):654-8. doi: 10.1038/sj.bjc.6600531. Br J Cancer. 2002. PMID: 12237776 Free PMC article.

4

Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma.

Watters AD, Going JJ, Cooke TG, Bartlett JM. Watters AD, et al. Breast Cancer Res Treat. 2003 Jan;77(2):109-14. doi: 10.1023/a:1021399923825. Breast Cancer Res Treat. 2003. PMID: 12602909

5

IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma.

Ainsworth R, Bartlett JM, Going JJ, Mallon EA, Forsyth A, Richmond J, Angerson W, Watters A, Dunne B. Ainsworth R, et al. J Clin Pathol. 2005 Oct;58(10):1086-90. doi: 10.1136/jcp.2004.021576. J Clin Pathol. 2005. PMID: 16189156 Free PMC article.

6

Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?

Bartlett JM, Watters AD, Ballantyne SA, Going JJ, Grigor KM, Cooke TG. Bartlett JM, et al. Among authors: watters ad. Br J Cancer. 1998 Jun;77(12):2193-8. doi: 10.1038/bjc.1998.365. Br J Cancer. 1998. PMID: 9649132 Free PMC article.

7

Evaluating HER2 amplification and overexpression in breast cancer.

Bartlett JM, Going JJ, Mallon EA, Watters AD, Reeves JR, Stanton P, Richmond J, Donald B, Ferrier R, Cooke TG. Bartlett JM, et al. Among authors: watters ad. J Pathol. 2001 Nov;195(4):422-8. doi: 10.1002/path.971. J Pathol. 2001. PMID: 11745673

8

Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres.

Dowsett M, Bartlett J, Ellis IO, Salter J, Hills M, Mallon E, Watters AD, Cooke T, Paish C, Wencyk PM, Pinder SE. Dowsett M, et al. Among authors: watters ad. J Pathol. 2003 Apr;199(4):418-23. doi: 10.1002/path.1313. J Pathol. 2003. PMID: 12635131

9

HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder.

Latif Z, Watters AD, Dunn I, Grigor KM, Underwood MA, Bartlett JM. Latif Z, et al. Among authors: watters ad. Br J Cancer. 2003 Oct 6;89(7):1305-9. doi: 10.1038/sj.bjc.6601245. Br J Cancer. 2003. PMID: 14520464 Free PMC article.

10

HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?

Latif Z, Watters AD, Dunn I, Grigor K, Underwood MA, Bartlett JM. Latif Z, et al. Among authors: watters ad. Eur J Cancer. 2004 Jan;40(1):56-63. doi: 10.1016/j.ejca.2003.08.027. Eur J Cancer. 2004. PMID: 14687790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters